ArticleMolecular and cellular biochemistry2008
DNase I-resistant DNA-dependent protein kinase activity in Xenopus oocytes.
Article in Molecular and cellular biochemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
- DNA-PK Deficiency in Alzheimer's Disease.Journal of neurology & neuromedicine · 2016Article
- Exogenously expressed human Ku70 stabilizes Ku80 in Xenopus oocytes and induces heterologous DNA-PK catalytic activity.Molecular and cellular biochemistry · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
DNA-dependent protein kinase (DNA-PK) is a nuclear serine/threonine protein kinase consisting of a catalytic subunit p460 (DNA-PKcs), and a DNA binding component termed Ku. DNA-PK plays a role in transcription, nonhomologous recombination, and DNA repair. Several reports have demonstrated that binding to double-stranded DNA (dsDNA) is required for the activation of DNA-PK. To date, very few reports suggest the possibility that an alternative pathway of DNA-PK activation exists without the requirement of dsDNA. In this study, direct biochemical evidence is presented to support this notion. Here, Xenopus oocytes were used as a model system because they offer the advantage of a manual enucleation process providing an extract that can be termed purely 'cytoplasmic' and the isolated nuclei (germinal vesicles) can be used to make nuclear extracts. Specific antibody-mediated pulled-down DNA-PK activity was assayed in the cytoplasmic extracts to evaluate the enzyme activity in the presence and absence of DNA. DNase I treatment did not affect the DNA-PK activity. Analyses of the association of nicked DNA with the pulled-down DNA-PK by radiolabeling the associated nicked DNA provided evidence that the cytoplasmic DNA-PK is catalytically active in absence of DNA. These results suggest that potential mechanisms occurring outside of the nucleus might activate DNA-PK, and therefore, could reveal novel functions of this enzyme.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.